Indiana University, Purdue University, and the University of Notre Dame invite all researchers to attend the Indiana Clinical and Translational Sciences Institute (CTSI) retreat. The event will take place at the University of Notre Dame’s McCourtney Hall on Friday, October 26, 2018 from 9:00 a.m. to 4:15 p.m.
Norman Dovichi, the Grace-Rupley Professor of Chemistry and Biochemistry, is the recipient of the inaugural College of Science Research Award.
The β-lactams are a vast family of antibiotics that include the well-known penicillins; they remain the most widely administered antibiotics around the globe. Results from the research of Jeff W. Peng, associate professor of chemistry and biochemistry, could reveal new strategies for coping with the expanding scope of β-lactam resistance now happening among Gram-negative pathogens.
Chen Dai, University of Notre Dame graduate student of chemistry and biochemistry, was recognized at the Indiana University (IU) Simon Cancer Center’s annual Cancer Research Day. Dai received first prize for his poster presentation in the basic science – graduate student category.
Structured Immunity, a Notre Dame startup and biotechnology company specializing in the optimization and validation of T cell receptor (TCR) proteins, and Medigene AG, a leading biotechnology company engaged in the development of immunotherapies for the treatment of cancer, today announced a research collaboration where Structured Immunity will provide structural immunology expertise in support of Medigene’s TCR discovery activities.
Brian Baker, Rev. John A. Zahm Professor, has received the Innovation Award from the American Cancer Society’s (ACS) local Coaches vs. Cancer program. The Innovation Award is described as being given to “an individual who demonstrates an innovative approach to treating or caring for cancer patients and their loved ones.”
Notre Dame continued the steady expansion and growth of its research, scholarship and creative endeavor programs during the most recent fiscal year, recording $141.6 million in research funding. The amount is part of a trend that has led to a 75 percent increase in external research funding awarded to the University compared to 10 years ago.
Nine faculty members from the College of Science and College of Engineering have been awarded four grants through the Center for Nano Science and Technology (NDnano) Seed Grant Program.
Beginning July 29, 2018, Notre Dame will host the 25th Biennial Conference on Chemical Education (BCCE). BCCE is a national meeting designed for college chemistry faculty, graduate students, secondary school chemistry teachers, and middle and elementary school science teachers to share ideas and best practices for chemical education.
Prashant Kamat, Rev. John A. Zahm Professor, well known for his contributions to the field of photoelectrochemistry and renewable energy research was honored with a tribute issue to him in one of the four journals of The Journal of Physical Chemistry, published by the American Chemical Society.
Trauma, or any kind of severe physical injury, continues to be today’s leading cause of death for people 46 and younger in the United States. In 2007, Dr. Scott Thomas and Dr. Mark Walsh of Memorial Hospital in South Bend were looking for a better way to treat trauma patients who arrived in the emergency room (ER) with excessive bleeding. Their search eventually led to a translational research collaboration with the W. M. Keck Center for Transgene Research at the University of Notre Dame and the development of a new method for treating trauma patients.
Notre Dame student Margo Waters has received the first Woodward Family Endowment for Excellence in NDnano Undergraduate Research.
In America, more than a million people suffer from diabetic foot ulcers.
In Latin, SalvePeds means “saving feet.”
And in SalvePeds, a new IDEA Center startup managed and marketed by a team of graduate students at the University of Notre Dame, patients may soon have a more effective option to treat diabetic foot ulcers and prevent some of the 100,000 amputations the condition necessitates every year.
University of Notre Dame licensee Hsiri Therapeutics, Inc., with its corporate headquarters located in Media, PA, has entered into a license agreement with Shionogi & Co., Ltd. regarding a collaborative licensing, research and development program to discover and develop novel therapeutics for non-tuberculous mycobacterial (NTM) diseases and tuberculosis (TB).
A study by researchers at the University of Notre Dame and the University of Missouri at Columbia shows in mice that early administration of a potent compound may increase the window of time in which some stroke patients can receive tPA, a therapeutic that dissolves blood clots.
Researchers at the University of Notre Dame have invented a new class of molecules that can be used to simplify the process used for capturing precious metals including gold, platinum, and palladium.
On Friday, May 18, 2018, more than 50 seniors were honored during The Dean’s Awards luncheon held in the Jordan Hall of Science Galleria.
Through the generosity of several donors, the Center for Stem Cells and Regenerative Medicine is able to provide summer research fellowships to six outstanding Notre Dame undergraduates this summer.
Patricia Clark, Rev. John Cardinal O’Hara C.S.C. Professor of Biochemistry, and Paul Huber, Professor of Chemistry & Biochemistry, have been selected as recipients of the 2018 Rev. Edmund P. Joyce C.S.C. Award for Excellence in Undergraduate Teaching.
